Evaluation of the Short-term Effect of Pemafibrate on Liver Fibrosis Biomarkers Stratified by FIB-4 Index in Patients with Type 2 Diabetes Mellitus and Hypertriglyceridemia

• Published in: Internal Medicine p. 5611-25
• Main Authors: Kitao, Takashi, Tanaka, Takumi, Kubori, Motohiro, Komoda, Yoshio, Mori, Yukiko, Ibata, Takeshi
• Format: Journal Article
• Language: English
• Published: Japan The Japanese Society of Internal Medicine 03.07.2025
• Subjects: hypertriglyceridemia; liver fibrosis marker; pemafibrate; Type 2 Diabetes; hypertriglyceridemia; pemafibrate; liver fibrosis marker; Type 2 Diabetes

Aims This study aimed to investigate the short-term effects of pemafibrate (PEMA) on the Fibrosis-4 index (FIB-4) and Aspartate Aminotransferase to Platelet Ratio Index (APRI) across three subgroups stratified according to FIB-4 for assessing the risk of liver fibrosis in patients with type 2 diabet...